Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Classement en actions #32454
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Prix de l'action
$0.04367217
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.06M
Changement (1 jour)
3.99%
Changement (1 an)
-26.77%
Pays
SE
Échange IDL Diagnostics AB (publ) (IDLDX)

Catégorie

Ratio P/S pour IDL Diagnostics AB (publ) (IDLDX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de IDL Diagnostics AB (publ), le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour IDL Diagnostics AB (publ) de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US